Table 3.
Comparison between classic PEL and classic Kaposi sarcoma.
| Classic PEL n=46 (%) |
Classic KS n=1593 (%) |
|
|---|---|---|
| Demographic characteristics | ||
| Age, meana, years | 76.8 | 68.8 |
| Male/Female | 5.57:1 | 2.76:1 |
| Country of originb | ||
| Italy | 21 (45.6) | 636 (39.9) |
| Greece | 6 (13) | 68 (4.3) |
| Spain | 4 (8.7) | 53 (3.3) |
| Portugal | 1 (2.2) | - |
| France | 3 (4.3) | 133 (8.3) |
| Moroccoc, Algeriad | 5 (10.8) | 56 (3.5) |
| Israel | 3 (6.5) | 248 (15.6) |
| Turkey | 2 (4.3) | 248 (15.6) |
| Lebanon | 1 (2.2) | - |
|
| ||
| Clinical characteristics b | ||
| Malignancies | 8/41 (19.5) | 78/519 (15) |
| Laboratory parameters, mean | ||
| Hemoglobin, g/dL | 11.68 (22) | 13.35 (53) |
| White blood cells, ×103/μL | 6.78 (21) | 7.04 (53) |
| Lymphocytes/μl | 1236 (15) | 2017 (121) |
| CD4 cells/μl | 255 (9) | 839 (68) |
| Death for disease | 27/37 (72.9) | 40/633 (6.3) |
a
To compare age at diagnosis, we calculated the weighted mean;
b
Number of patients (%);
c
Morocco (2 cases);
d
Algeria (3 cases).